Clinical Stage IV Gastric Cancer AJCC v8 Recruiting Phase 0 Trials for Pembrolizumab (DB09037)

IndicationStatusPhase
DBCOND0113387 (Clinical Stage IV Gastric Cancer AJCC v8)Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05041153Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal AdenocarcinomaTreatment